Beijing Geneplus Technology
PrivateLast Round
Series D
Nov 30, 2025
Est. Valuation
$597.22M
Total Funding Raised
$333.44M
Company Overview
Beijing Geneplus Technology is a biotechnology company that provides a range of services and products for cancer precision medicine based on next-generation sequencing (NGS) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Geneplus Technology Comparables
Compare Beijing Geneplus Technology with similar companies based on industry and business-model similarity.
Beijing Geneplus Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Nov 30, 2025 | ||||
| Series D | Dec 1, 2023 | ||||
| Series C | Jul 22, 2021 | ||||
| Series B Extension | Nov 16, 2020 | ||||
| Series B | Jul 31, 2019 | ||||
Series B | Jul 1, 2019 |
Beijing Geneplus Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing Chang Development | Series D |
| Chuanghehui Capital | Series C |
| 蔚亭资本 | Series C |
| Highlight Capital | Series B Extension |
| Jiangsu Honghui Equity Investment Management | Series B Extension |
| Jiyuan Capital | Series C |
| Desun Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2023
Raised $42.3M led by changfazhan
- Jul 22, 2021
$116M round led by CCB International.
Beijing Geneplus Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Geneplus Technology's valuation, stock price, and market status.
Is Beijing Geneplus Technology a public or private company?
Beijing Geneplus Technology is a private company.
What is the current stock price of Beijing Geneplus Technology?
Beijing Geneplus Technology is a private company with no public stock price. No recent secondary market data is available.
How much is Beijing Geneplus Technology worth (valuation)?
Beijing Geneplus Technology's valuation is estimated at $597.2M based on funding round data.
Can I buy Beijing Geneplus Technology stock?
Beijing Geneplus Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Geneplus Technology's last funding round?
Beijing Geneplus Technology's most recent funding round was Series D on November 30, 2025.
Who are the main investors in Beijing Geneplus Technology?
Key investors in Beijing Geneplus Technology include CCB International, Huagai Capital, CoStone Capital, CoStone Capital.
Will Beijing Geneplus Technology IPO soon?
No public IPO plans have been announced for Beijing Geneplus Technology.
How can I track Beijing Geneplus Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Geneplus Technology's secondary market activity and sign up for updates.